You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 69 Issue 1

January 2010

Volume 69, Issue 1

Pages 1–106

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Editors' Report, November 2009 (page 1)

      YK Loke, AF Cohen, A Ferro, LD Lewis, JM Ritter and A Somogyi

      Version of Record online: 23 DEC 2009 | DOI: 10.1111/j.1365-2125.2009.03603.x

  2. New drug mechanisms

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Retapamulin (pages 2–3)

      Eline A. Dubois and Adam F. Cohen

      Version of Record online: 21 JUL 2009 | DOI: 10.1111/j.1365-2125.2009.03505.x

  3. Systematic review

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have full text access to this OnlineOpen article
      Validation and validity of diagnoses in the General Practice Research Database: a systematic review (pages 4–14)

      Emily Herrett, Sara L. Thomas, W. Marieke Schoonen, Liam Smeeth and Andrew J. Hall

      Version of Record online: 1 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03537.x

      • image
      • image
      • image
  4. Pharmacodynamics

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974) (pages 15–22)

      Simon R. Sinclair, Stefanie A. Kane, Bart J. Van der Schueren, Alan Xiao, Kenneth J. Willson, Janet Boyle, Inge De Lepeleire, Yang Xu, Lisa Hickey, William S. Denney, Chi-Chung Li, John Palcza, Floris H. M. Vanmolkot, Marleen Depré, Anne Van Hecken, M. Gail Murphy, Tony W. Ho and Jay N. De Hoon

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03543.x

      • image
      • image
  5. Pharmacokinetics

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have full text access to this OnlineOpen article
      The effects of sitaxentan on sildenafil pharmacokinetics and pharmacodynamics in healthy subjects (pages 23–26)

      Fiona Stavros, William G. Kramer and Martin R. Wilkins

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03541.x

    2. You have free access to this content
  6. Pharmacokinetic dynamic relationships

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy (pages 38–50)

      Laurent R. Chiarelli, Mariadelfina Molinaro, Carmelo Libetta, Carmine Tinelli, Laura Cosmai, Giovanna Valentini, Antonio Dal Canton and Mario Regazzi

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03542.x

      • image
      • image
      • image
      • image
      • image
  7. Drug interactions

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Assessment of the pharmacokinetics of co-administered maraviroc and raltegravir (pages 51–57)

      Emma Andrews, Paul Glue, Juanzhi Fang, Penelope Crownover, Randall Tressler and Bharat Damle

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03546.x

      • image
      • image
      • image
      • image
  8. Pharmacogenetics

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients (pages 58–66)

      Marie-Christine Etienne-Grimaldi, Gérard Milano, Frédérique Maindrault-Gœbel, Benoist Chibaudel, Jean-Louis Formento, Mireille Francoual, Gérard Lledo, Thierry André, May Mabro, Laurent Mineur, Michel Flesch, Elisabeth Carola and Aimery De Gramont

      Version of Record online: 8 OCT 2009 | DOI: 10.1111/j.1365-2125.2009.03556.x

      • image
      • image
  9. Drug safety

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      A computerized system for detecting signals due to drug–drug interactions in spontaneous reporting systems (pages 67–73)

      Yifeng Qian, Xiaofei Ye, Wenmin Du, Jingtian Ren, Yalin Sun, Hainan Wang, Baozhang Luo, Qingbin Gao, Meijing Wu and Jia He

      Version of Record online: 8 OCT 2009 | DOI: 10.1111/j.1365-2125.2009.03557.x

  10. Pharmacoepidemiology

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Adherence level of antihypertensive agents in coronary artery disease (pages 74–84)

      Sylvie Perreault, Alice Dragomir, Louise Roy, Michel White, Lucie Blais, Lyne Lalonde and Anick Bérard

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03547.x

      • image
      • image
    2. You have free access to this content
      Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database (pages 85–94)

      Sara Lodi, Stephen J. W. Evans, Peter Egger and James Carpenter

      Version of Record online: 8 OCT 2009 | DOI: 10.1111/j.1365-2125.2009.03560.x

      • image
  11. Short report

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men (pages 95–98)

      Fabiana B. Kohlrausch, Rita De Cássia Estrela, Paulo F. Barroso and Guilherme Suarez-Kurtz

      Version of Record online: 22 SEP 2009 | DOI: 10.1111/j.1365-2125.2009.03551.x

      • image
  12. Letter to the editors

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Severe toxicity related to a pharmacokinetic interaction between docetaxel and ritonavir in HIV-infected patients (pages 99–101)

      Olivier Mir, Bernadette Dessard-Diana, Agnès Lillo-Le Louet, Pierre Loulergue, Jean-Paul Viard, Anne Langlois, Catherine Durdux and Christine Le Beller

      Version of Record online: 8 OCT 2009 | DOI: 10.1111/j.1365-2125.2009.03555.x

  13. Mandarin translations section

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Systematic review
    5. Pharmacodynamics
    6. Pharmacokinetics
    7. Pharmacokinetic dynamic relationships
    8. Drug interactions
    9. Pharmacogenetics
    10. Drug safety
    11. Pharmacoepidemiology
    12. Short report
    13. Letter to the editors
    14. Mandarin translations section
    1. You have free access to this content
      Translation Section (pages 102–106)

      Version of Record online: 23 DEC 2009 | DOI: 10.1111/j.1365-2125.2009.03602.x

SEARCH

SEARCH BY CITATION